Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering strategies and binding mechanisms of therapeutic anti-PD-1 antibodies approved by regulatory agencies globally.

Frontiers in immunology·2026
Same author

The immune system in Latin America and the Caribbean: Insights into diseases and diversity from local perspectives.

Seminars in immunology·2026
Same author

Dynamics of Interleukin-9 Producing Lymphocytes in <i>Strongyloides ratti</i>-Infected Mice.

Pathogens (Basel, Switzerland)·2026
Same author

T<sub>H</sub>9 cells and interleukin-9 in parasitic infections: Updates, opportunities, and challenges.

Seminars in immunology·2025
Same author

TGF-β: A silent player regulating CD8 T cell memory.

Clinical immunology (Orlando, Fla.)·2025
Same author

Women in STEM becoming independent: People should feel free to be themselves and do great science.

The Journal of experimental medicine·2025

Related Experiment Video

Updated: Sep 7, 2025

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
08:38

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

1.4K

IL-33 and the PKA Pathway Regulate ILC2 Populations Expressing IL-9 and ST2.

Enrique Olguín-Martínez1, Ofelia Muñoz-Paleta1, Blanca E Ruiz-Medina1

  • 1Departamento de Biología Celular y del Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México City, Mexico.

Frontiers in Immunology
|June 17, 2022
PubMed
Summary

Type 2 innate lymphoid cells (ILC2s) produce IL-9, crucial for immunity. This study reveals IL-33 and the PKA pathway synergistically enhance IL-9 production in ILC2s, highlighting subset heterogeneity.

Keywords:
IL-33IL-9ILC2PKAST2pathwayregulation

More Related Videos

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
08:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

2.0K
Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
10:30

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice

Published on: January 25, 2017

8.9K

Related Experiment Videos

Last Updated: Sep 7, 2025

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
08:38

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

1.4K
Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
08:30

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

2.0K
Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
10:30

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice

Published on: January 25, 2017

8.9K

Area of Science:

  • Immunology
  • Cell Biology
  • Parasitology

Background:

  • Type 2 innate lymphoid cells (ILC2s) are key players in type 2 immunity, responding to tissue damage.
  • ILC2s produce IL-9, a critical cytokine for anti-helminth immunity and allergy, but regulatory mechanisms remain unclear.
  • ILC2 function can be modulated by various stimuli, including lipid mediators and neuropeptides activating the PKA pathway.

Purpose of the Study:

  • To investigate the stimuli regulating IL-9 expression in ILC2s during helminth infection.
  • To characterize distinct ILC2 subsets based on IL-9 and ST2 expression.
  • To elucidate the role of the PKA pathway in ILC2 function.

Main Methods:

  • Development of an in vitro culture system for mouse ILC2s.
  • Infection of mice with *N. brasiliensis* to study ILC2 populations in vivo.
  • Analysis of IL-9 and ST2 expression on ILC2 subsets.
  • Investigation of IL-33 and PKA pathway activation on ILC2s.

Main Results:

  • ILC2s in infected mice exhibited heterogeneity in IL-9 and ST2 expression, found in lungs and small intestine.
  • The alarmin IL-33 was identified as a key stimulus for increased IL-9 production by ILC2s.
  • The PKA pathway acted synergistically with IL-33 to boost IL-9 production and modulated ILC2 proliferation and marker expression.

Conclusions:

  • ILC2 populations are heterogeneous and context-dependent, necessitating careful marker selection for in vivo identification.
  • IL-33 and the PKA pathway are critical regulators of IL-9 production in ILC2s.
  • Understanding ILC2 subset mechanisms is vital for therapeutic applications in type 2 immunity-related diseases.